These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 11799348

  • 1. Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system.
    Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, Almerighi C, Verkerk R, Meltzer H, Maes M.
    J Clin Psychopharmacol; 2002 Feb; 22(1):86-90. PubMed ID: 11799348
    [Abstract] [Full Text] [Related]

  • 2. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
    Vignau J, Costisella O, Canva V, Imbenotte M, Duhamel A, Lhermitte M.
    Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation.
    Maes M, Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, Almerighi C, Meltzer H.
    Mol Psychiatry; 2001 Jul; 6(4):475-80. PubMed ID: 11443537
    [Abstract] [Full Text] [Related]

  • 5. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
    Wichers MC, Koek GH, Robaeys G, Verkerk R, Scharpé S, Maes M.
    Mol Psychiatry; 2005 Jun; 10(6):538-44. PubMed ID: 15494706
    [Abstract] [Full Text] [Related]

  • 6. The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-α2a and oral ribavirin.
    Pawlowski T, Pawlak D, Inglot M, Zalewska M, Marciniak D, Bugajska J, Janocha-Litwin J, Malyszczak K.
    J Psychiatry Neurosci; 2021 Jan 18; 46(1):E166-E175. PubMed ID: 33464780
    [Abstract] [Full Text] [Related]

  • 7. Lower activities of serum peptidases predict higher depressive and anxiety levels following interferon-alpha-based immunotherapy in patients with hepatitis C.
    Maes M, Bonaccorso S.
    Acta Psychiatr Scand; 2004 Feb 18; 109(2):126-31. PubMed ID: 14725594
    [Abstract] [Full Text] [Related]

  • 8. Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C.
    Comai S, Cavalletto L, Chemello L, Bernardinello E, Ragazzi E, Costa CV, Bertazzo A.
    Pharmacol Res; 2011 Jan 18; 63(1):85-92. PubMed ID: 20940053
    [Abstract] [Full Text] [Related]

  • 9. A biopsychosocial model of interferon-alpha-induced depression in patients with chronic hepatitis C infection.
    Baranyi A, Meinitzer A, Stepan A, Putz-Bankuti C, Breitenecker RJ, Stauber R, Kapfhammer HP, Rothenhäusler HB.
    Psychother Psychosom; 2013 Jan 18; 82(5):332-40. PubMed ID: 23942342
    [Abstract] [Full Text] [Related]

  • 10. Depressive symptoms as a side effect of Interferon-α therapy induced by induction of indoleamine 2,3-dioxygenase 1.
    Murakami Y, Ishibashi T, Tomita E, Imamura Y, Tashiro T, Watcharanurak K, Nishikawa M, Takahashi Y, Takakura Y, Mitani S, Fujigaki H, Ohta Y, Kubo H, Mamiya T, Nabeshima T, Kim HC, Yamamoto Y, Saito K.
    Sci Rep; 2016 Jul 20; 6():29920. PubMed ID: 27436416
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Hepatitis C, interferon a and depression: main physiopathologic hypothesis].
    Vignau J, Karila L, Costisella O, Canva V.
    Encephale; 2005 Jul 20; 31(3):349-57. PubMed ID: 16142050
    [Abstract] [Full Text] [Related]

  • 13. HTR1A, TPH2, and 5-HTTLPR Polymorphisms and Their Impact on the Severity of Depressive Symptoms and on the Concentration of Tryptophan Catabolites during Hepatitis C Treatment with Pegylated Interferon-α2a and Oral Ribavirin (PEG-IFN-α2a/RBV).
    Pawlowski T, Malyszczak K, Pawlak D, Inglot M, Zalewska M, Grzywacz A, Radkowski M, Laskus T, Janocha-Litwin J, Frydecka D.
    Cells; 2023 Mar 22; 12(6):. PubMed ID: 36980311
    [Abstract] [Full Text] [Related]

  • 14. Depressive symptoms in patients with hepatitis C treated with pegylated interferon alpha therapy: a 24-week prospective study.
    Pavlović Z, Delić D, Marić NP, Vuković O, Jašović-Gašić M.
    Psychiatr Danub; 2011 Dec 22; 23(4):370-7. PubMed ID: 22075738
    [Abstract] [Full Text] [Related]

  • 15. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.
    Raison CL, Dantzer R, Kelley KW, Lawson MA, Woolwine BJ, Vogt G, Spivey JR, Saito K, Miller AH.
    Mol Psychiatry; 2010 Apr 22; 15(4):393-403. PubMed ID: 19918244
    [Abstract] [Full Text] [Related]

  • 16. Depressive symptoms following interferon-α therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor?
    Kenis G, Prickaerts J, van Os J, Koek GH, Robaeys G, Steinbusch HW, Wichers M.
    Int J Neuropsychopharmacol; 2011 Mar 22; 14(2):247-53. PubMed ID: 20667172
    [Abstract] [Full Text] [Related]

  • 17. Early increase in vegetative symptoms predicts IFN-alpha-induced cognitive-depressive changes.
    Wichers MC, Koek GH, Robaeys G, Praamstra AJ, Maes M.
    Psychol Med; 2005 Mar 22; 35(3):433-41. PubMed ID: 15841878
    [Abstract] [Full Text] [Related]

  • 18. Quinolinic Acid Responses during Interferon-α-Induced Depressive Symptomatology in Patients with Chronic Hepatitis C Infection - A Novel Aspect for Depression and Inflammatory Hypothesis.
    Baranyi A, Meinitzer A, Breitenecker RJ, Amouzadeh-Ghadikolai O, Stauber R, Rothenhäusler HB.
    PLoS One; 2015 Mar 22; 10(9):e0137022. PubMed ID: 26368809
    [Abstract] [Full Text] [Related]

  • 19. Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: evidence for an overlap between manic/hypomanic and depressive symptoms.
    Constant A, Castera L, Dantzer R, Couzigou P, de Ledinghen V, Demotes-Mainard J, Henry C.
    J Clin Psychiatry; 2005 Aug 22; 66(8):1050-7. PubMed ID: 16086622
    [Abstract] [Full Text] [Related]

  • 20. Alterations in the metabolism of tryptophan in patients with chronic hepatitis C six months after pegylated interferon-α 2a treatment.
    Pawlowski T, Malyszczak K, Inglot M, Zalewska M, Radkowski M, Laskus T, Pawlak D.
    Psychoneuroendocrinology; 2018 Nov 22; 97():1-7. PubMed ID: 29990677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.